Navigation Links
Molecular Therapy Succeeds in Preventing Craniofacial Birth Defect in Mice
Date:2/6/2008

a copy of the mutated gene to the child.

"Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function" by Natalie C. Jones, Paul A Trainor, et al. was published February 3, 2008 online by Nature Medicine, doi:10.1038/nm1725.

The March of Dimes is the leading nonprofit organization for pregnancy and baby health. With chapters nationwide and its premier event, March for Babies(sm), the March of Dimes works to improve the health of babies. For the latest resources and information, visit marchofdimes.com or nacersano.org.


'/>"/>
SOURCE March of Dimes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
2. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
3. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
4. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
5. Tapestry Pharmaceuticals Presents Data on TPI 287 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
8. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
9. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
10. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Onyx Pharmaceuticals,...l host an investor teleconference and webcast. Pr...tations surrounding carfilzomib in relapsed and/or...1st American Society of Hematology (ASH) Annual Me... a.m. CT/10:00 a.m. ET on Monday, December 7, 2009...
(Date:12/4/2009)...RNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Am...l countermeasures against biological and chemical ...ata from the Company,s anthrax vaccine program sho...ntigen (rPA) based anthrax vaccine is structurally...eratures up to and including 55 degrees C. The da...
(Date:12/4/2009)...ewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex...countermeasures against biological and chemical th...ing results of a study demonstrating the effective...del in the New Zealand White (NZW) rabbit. The da...he HHS Public Health Emergency Medical Countermeas...
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Satellite Healthcare Helps Support the Cure for Kidney Disease in Sacramento 57472 1Satellite Healthcare Helps Support the Cure for Kidney Disease in Sacramento 57472 2Nutrisystem and House Foods Announce Licensing Agreement To Market Nutrisystem J Diet in Japan 57468 1Nutrisystem and House Foods Announce Licensing Agreement To Market Nutrisystem J Diet in Japan 57468 2Nutrisystem and House Foods Announce Licensing Agreement To Market Nutrisystem J Diet in Japan 57468 3Sunlight Saunas Celebrates 10 Years of Industry Firsts and Announces 10th Anniversary Sweepstakes Winner 57465 1Sunlight Saunas Celebrates 10 Years of Industry Firsts and Announces 10th Anniversary Sweepstakes Winner 57465 2
...9, 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq:ACAD...ts Phase II schizophrenia co-therapy trial with AC...nverse agonist. The trial,evaluated ACP-103 co-the... commonly prescribed atypical antipsychotic drug, ...ug. The co-therapy,arms with ACP-103 demonstrated ...
...nical Data on XIENCE V Everolimus,Eluting Corona...Results from the ABSORB Bioabsorbable Stent Clinic...ewswire-FirstCall/ --,Abbott will present data f...rtfolio and pipeline during a number of late-break... Cardiology,s 56th,Annual Scientific Session bei...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 2Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 3Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 4Abbott to Present New Data Across its Vascular Portfolio at the,American College of Cardiology's 56th Annual Scientific Session 5
(Date:12/4/2009)...SHINGTON, Dec. 4 In res...ent Agency,s (DEA) classification of boldione, des...dienedione as "anabolic steroids", under the Contr...rector and CEO of the Natural Products Association...representing retailers and manufacturers of dietar...
(Date:12/4/2009)...5 million Americans are recruited annually to part...ce for Human Research Protection (AHRP), and most ... Research institutions view payments to voluntee...ompensation for potential risks related to partici...that volunteers have a very different view of clin...
(Date:12/4/2009)... to pressure from federal regulators to crack down...AY, Dec. 4 (HealthDay News) -- The makers of 24 di...ed federal regulators with plans to curb the abuse...ompanies have been under pressure from U.S. Food a...stop the hundreds of fatal overdoses that occur wi...
(Date:12/4/2009)...olesterol-lowering drugs known as statins are amon...new study by researchers at Fred Hutchinson Cancer...t stem cell transplant patients from one of the mo... therapy: graft-versus-host disease, or GVHD. The ...of the journal Blood . , In a retrospective stud...
(Date:12/4/2009)...ADISON, Wis., Dec. 4 Whe...e Wisconsin Department of Health Services needed t... than ever before. Join Sonic Foundry, Inc. (Nas...h media webcasting and knowledge management, for a...in Department of Health Services, will share how i...
Breaking Medicine News(10 mins):Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
....Y., April 6 What is the relationship between lat...tudy examined this relationship. The scientists me... identical twins, that is, individuals with an ide...he results showed that the twin that carried the l...
...ICAGO, April 6 The U.S. economy transmits over 18...imately half of all healthcare financial transac...ing, postage and labor for manual processes in hea... administrative savings represent a bright spot --...
...Improves Survival Would Earn a 50 Percent Patient ...n Europe , According to a New Report from Decis...sion Resources, one of the world,s leading researc...attribute that most influences their prescribing d...
...INS, N.J., April 6, 2009 New head-to-head clinica...Toothbrush and Floss deliver superior plaque remov...on Healthcare Products Division of McNEIL-PPC, Inc...:, , REACH ULTRACLEAN Floss removes up to two t...
...l 6 At least 20 million Europeans suffer from chr...additional ten million experience occasional sleep...itnessed a rise in patient volume by ten per cent ... in the number of sleep service providers across E...
....Y., April 6 Computer Intuition is a psycholingui...on,s written or spoken language and retrieves info...s, Computer Intuition was used to analyze focus gr...hildren,s museum became interested in increasing i...
Other Medicine News:Health News:Effective Weight Management with Gene-Eden, a New Dietary Supplement Based on Dr. Hanan Polansky's Discovery 2Health News:Whitepaper Shines Light on Administrative Waste: Offers Practical Steps for Cutting Healthcare Costs through Existing Infrastructure, Collaboration 2Health News:Whitepaper Shines Light on Administrative Waste: Offers Practical Steps for Cutting Healthcare Costs through Existing Infrastructure, Collaboration 3Health News:Interviewed Experts Expect Taxotere to Increase Overall Survival More Than Other Drugs, Including Lupron Depot, in Stage III Prostate Cancer 2Health News:Interviewed Experts Expect Taxotere to Increase Overall Survival More Than Other Drugs, Including Lupron Depot, in Stage III Prostate Cancer 3Health News:New head-to-head clinical studies reveal Reach Ultraclean toothbrush and floss deliver superior plaque removal compared to leading competitive products 2Health News:Rise in Sleeping Disorders Triggers High Demand for Sleep Service Facilities in Europe, Notes Frost & Sullivan 2Health News:Rise in Sleeping Disorders Triggers High Demand for Sleep Service Facilities in Europe, Notes Frost & Sullivan 3Health News:Rise in Sleeping Disorders Triggers High Demand for Sleep Service Facilities in Europe, Notes Frost & Sullivan 4Health News:How Can We Improve Our Elementary School System? - Unique Market Research Analysis of the Subconscious of Parents 2
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: